PRISMAP outcomes

PRISMAP produces a wide range of results that we make available to you:

As a research project, PRISMAP publishes results in peer-reviewed scientific journals and other non peer-reviewed venues, and also makes detailed reports – called 'deliverables' – available, if they can be made publicly accessible.

We also make available recordings of the webinars and training sessions organised by PRISMAP, along with the material created to describe the project and how it works.

You can also find links to our funded projects page and to our educational resources, which are part of our multi-faceted outcomes.

Publications by the PRISMAP project

Publishable summary

Download the latest project summary detailing the status of PRISMAP as prepared for the EU funding body and the public.

PRISMAP sustainability white paper

As PRISMAP aims for long-term sustainability, this white paper identifies different directions to further develop access services and prepare for a mature European medical radionuclide programme PRISMAP+. Here we make a publishable extract of it available.

Public deliverables

Deliverables are reports to the EU funding body on the results achieved for one or more project tasks.
1.
Sustainability plan.
(2025). doi:10.5281/ZENODO.18034767
2.
User projects.
(2025). doi:10.5281/zenodo.17898315
3.
User Meetings.
(2025). doi:10.5281/ZENODO.16871554
4.
Quality data collection for clinical translation.
(2025). doi:10.5281/ZENODO.16612998
5.
Standards for clinical translation.
(2022). doi:10.5281/ZENODO.6599181

Scientific publications

Publications in peer-reviewed journals, conference proceedings, book chapters and books.
1.
Cytotoxicity and cell cycle changes in prostate cancer cells with differing PSMA expression and p53 status after treatment with PSMA-targeting radioligand [212Pb]Pb-AB001.
Scientific Reports (2025). doi:10.1038/s41598-025-29785-7. Archive: pubmed
2.
Navigating the safety profile of Actinium-225 targeted alpha therapy: a comprehensive review.
Clinical and Translational Imaging (2025). doi:10.1007/s40336-025-00733-9. Archive: zenodo
3.
Validation of ICP-OES and γ-spectrometry methodologies for quality assessment of 67Cu from cyclotron production via the 70Zn(p,α)67Cu nuclear reaction.
Journal of Radioanalytical and Nuclear Chemistry 334, 5637–5648 (2025). doi:10.1007/s10967-025-10270-4. Archive: Orbit
4.
Two-step extraction chromatography separation of 161Tb from 160Gd-enriched irradiated target material and verification of the [161Tb]TbCl3 suitability for radiolabelling.
Applied Radiation and Isotopes 226, 112144 (2025). doi:10.1016/j.apradiso.2025.112144. Archive: PMC
5.
First ion source at ISOL@MYRRHA with an improved thermal profile - Theoretical considerations.
Journal of Physics: Conference Series 2743, 012065 (2024). doi:10.1088/1742-6596/2743/1/012065. Archive: LIRIAS
 

Publications by the funded projects

PRISMAP selects projects for funding and serves as provider of radionuclides and medical application services for these projects.

The selected projects are presented on our access platform with title, leader, keywords, a publishable abstract and, if available, a summary of the results and a list of related publications.

1.
A true theranostic pair – 44/47Sc-labeled GRPR antagonist shows great promise for managing prostate and breast cancer.
European Journal of Nuclear Medicine and Molecular Imaging (2025). doi: 10.1007/s00259-025-07651-y
2.
Different 212Pb Generators and Its Radiation Safety Concerning 220Rn (Thoron) Emanation.
Toxics 13, 462 (2025). doi: 10.3390/toxics13060462
3.
Optimised solid-phase extraction of 211At: Activity balance of 211At, 210At and 210Po after wet chemistry target dissolution.
Radiation Physics and Chemistry 225, 112146 (2024). doi: 10.1016/j.radphyschem.2024.112146
4.
Preclinical Evaluation of Gastrin-Releasing Peptide Receptor Antagonists Labeled with 161 Tb and 177 Lu: A Comparative Study.
Journal of Nuclear Medicine jnumed.123.266233 (2023). doi: 10.2967/jnumed.123.266233

Webinars and trainings

PRISMAP provides training for the highly multidisciplinary and fragmented research community.

A common understanding and common terms will enable users, service providers and regulators to speak the same language.

Recordings of previous webinars promoted by PRISMAP look at production of radionuclides, regulatory aspects, theranostics.

For a full list of events, webinars and training sessions organised by the project, please visit our events page.

Project presentation

With this series of short videos and the flyer, we would like to introduce the project, its goals and its way of working to a wide audience.

Educational content

PRISMAP offers education and training resources aimed at high school or early university students, but anyone is welcome to use them.

The available information can be downloaded from the dedicated educational resources section of our website and freely used in educational settings.